Nicotine Oral Pouches for Public Health Study

(THRIVE Trial)

This trial aims to understand how people use nicotine oral pouches. Researchers are testing two types of pouches with different particle sizes to observe variations in usage patterns. Participants will attend three study visits and try two types of nicotine pouches, while maintaining a daily diary to track their use. This trial suits adults who have used nicotine pouches daily for at least the past three months and consume at least 1.5 cans per week. As a Phase 4 trial, the treatment has already received FDA approval and proven effective, allowing researchers to understand how it benefits more patients.

The trial protocol does not specify whether you need to stop taking your current medications. However, you must abstain from tobacco, nicotine, and marijuana for at least 12 hours before study visits.

Research has shown that nicotine oral pouches, regardless of size, are generally well-tolerated, but they are not without risks. Some studies have identified cases of nicotine poisoning from these pouches, though these cases have not been serious. While nicotine is less harmful than smoking, it remains toxic.

Some nicotine pouches also contain harmful substances like formaldehyde and chromium, which can increase health risks. Although these pouches do not contain tobacco leaves and are not considered cancer-causing, they expose users to fewer harmful chemicals than cigarettes.

Researchers are excited about nicotine oral pouches because they offer a smokeless and potentially less harmful alternative to traditional tobacco products like cigarettes and chewing tobacco. Unlike these conventional options, the nicotine oral pouches deliver nicotine without involving combustion or tobacco leaf, reducing exposure to harmful chemicals. Additionally, the study is exploring different particle sizes of the nicotine pouches, which could affect how the body absorbs nicotine, potentially offering a more customizable and effective way to help individuals reduce or quit smoking. This innovative approach could make nicotine replacement more appealing and accessible, supporting public health efforts to decrease smoking rates.

This trial will compare small particle size oral nicotine pouches with variable particle size oral nicotine pouches. Studies have shown that nicotine oral pouches are less harmful than cigarettes but still deliver a similar amount of nicotine, making them a potential alternative for smokers. Research suggests that particle size differences in these pouches might influence user experience. However, even though they pose less risk than traditional cigarettes, nicotine pouches are not completely safe. They can lead to addiction, and their long-term health effects remain unclear. While they may reduce some smoking-related risks, caution is advised when using them.²³⁴⁶⁷